BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34705780)

  • 21. A
    Pess GM; Sundbom M; Wilson K; Lindqvist D; Dahlin LB
    J Plast Surg Hand Surg; 2018 Oct; 52(5):301-306. PubMed ID: 30039732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of collagenase treatment for Dupuytren's disease: 2-year follow-up results.
    Van Beeck A; Van den Broek M; Michielsen M; Didden K; Vuylsteke K; Verstreken F
    Hand Surg Rehabil; 2017 Oct; 36(5):346-349. PubMed ID: 28732844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Use of Residual Collagenase for Single Digits With Multiple-Joint Dupuytren Contractures.
    Grandizio LC; Akoon A; Heimbach J; Graham J; Klena JC
    J Hand Surg Am; 2017 Jun; 42(6):472.e1-472.e6. PubMed ID: 28389081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Collagenase injections for Dupuytren disease: 3-year treatment outcomes and predictors of recurrence in 89 hands.
    Nordenskjöld J; Lauritzson A; Åkesson A; Atroshi I
    Acta Orthop; 2019 Dec; 90(6):517-522. PubMed ID: 31500473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Finger Joint Contractures 5 Years After Treatment for Dupuytren Disease: A Comparative Cohort Study of Collagenase Injection Versus Surgical Fasciectomy.
    Eckerdal D; Lauritzson A; Nordenskjöld J; Åkesson A; Atroshi I
    J Hand Surg Am; 2022 Sep; 47(9):834-842. PubMed ID: 35868901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective randomized controlled trial comparing 1- versus 7-day manipulation following collagenase injection for dupuytren contracture.
    Mickelson DT; Noland SS; Watt AJ; Kollitz KM; Vedder NB; Huang JI
    J Hand Surg Am; 2014 Oct; 39(10):1933-1941.e1. PubMed ID: 25194768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Five-Year Results of a Randomized, Controlled Trial of Collagenase Treatment Compared With Needle Fasciotomy for Dupuytren Contracture.
    Byström M; Ibsen Sörensen A; Samuelsson K; Fridén JO; Strömberg J
    J Hand Surg Am; 2022 Mar; 47(3):211-217. PubMed ID: 35074248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term efficacy and safety of collagenase injection for Dupuytren's contracture: Therapy protocol for successful outcomes in a clinical setting.
    Sakai A; Zenke Y; Menuki K; Yamanaka Y; Tajima T; Tsukamoto M; Uchida S
    J Orthop Sci; 2019 May; 24(3):434-440. PubMed ID: 30392714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse effects associated with collagenase clostridium histolyticum in Dupuytren disease: A prospective study.
    Sanjuan-Cerveró R; Carrera-Hueso FJ; Vazquez-Ferreiro P
    Orthop Traumatol Surg Res; 2018 Oct; 104(6):901-905. PubMed ID: 30253866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary soft-tissue distraction versus checkrein ligament release after fasciectomy in the treatment of dupuytren proximal interphalangeal joint contractures.
    Craft RO; Smith AA; Coakley B; Casey WJ; Rebecca AM; Duncan SFM
    Plast Reconstr Surg; 2011 Nov; 128(5):1107-1113. PubMed ID: 21738085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes and Direct Costs of Needle Aponeurotomy, Collagenase Injection, and Fasciectomy in the Treatment of Dupuytren Contracture.
    Leafblad ND; Wagner E; Wanderman NR; Anderson GR; Visscher SL; Maradit Kremers H; Larson DR; Rizzo M
    J Hand Surg Am; 2019 Nov; 44(11):919-927. PubMed ID: 31537401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-Year Recurrence of Dupuytren Contracture after Needle Fasciotomy or Collagenase Injection: A Randomized Controlled Trial.
    Jørgensen RW; Jensen CH; Jørring S
    Plast Reconstr Surg; 2023 Feb; 151(2):365-371. PubMed ID: 36342689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Recurrent Dupuytren Contracture in Joints Previously Effectively Treated With Collagenase Clostridium histolyticum.
    Bear BJ; Peimer CA; Kaplan FTD; Kaufman GJ; Tursi JP; Smith T
    J Hand Surg Am; 2017 May; 42(5):391.e1-391.e8. PubMed ID: 28341067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New insights into the immediate outcome of collagenase injections for Dupuytren's contracture.
    Warwick DJ; Graham D; Worsley P
    J Hand Surg Eur Vol; 2016 Jul; 41(6):583-8. PubMed ID: 26307140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Collagenase Treatment for Dupuytren Disease of the Thumb and First Web.
    Dreise MM; Stenekes MW; Werker PM
    J Hand Surg Am; 2016 Mar; 41(3):348-53.e1. PubMed ID: 26803569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of percutaneous needle fasciotomy and collagenase injection for dupuytren disease.
    Nydick JA; Olliff BW; Garcia MJ; Hess AV; Stone JD
    J Hand Surg Am; 2013 Dec; 38(12):2377-80. PubMed ID: 24060510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The quantitative role of flexor sheath incision in correcting Dupuytren proximal interphalangeal joint contractures.
    Blazar PE; Floyd EW; Earp BE
    J Hand Surg Eur Vol; 2016 Jul; 41(6):609-13. PubMed ID: 26342010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of Dupuytren Contractures After Collagenase Clostridium Histolyticum Injection: A Single-institution Experience.
    Hwee YK; Park D; Vinas M; Litts C; Friedman D
    Ann Plast Surg; 2017 Aug; 79(2):145-148. PubMed ID: 28604542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of Management of Recurrent Dupuytren Contracture: A Systematic Review and Meta-analysis.
    Wong CR; Huynh MNQ; Fageeh R; McRae MC
    Hand (N Y); 2022 Nov; 17(6):1104-1113. PubMed ID: 33618538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk Factors for Skin Tears Following Collagenase Clostridium histolyticum to Treat Dupuytren Contractures.
    Wei DH; Cantlon MB; Wakefield DB; Vitale MA
    J Hand Surg Am; 2020 Oct; 45(10):989.e1-989.e10. PubMed ID: 32546304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.